Published in Blood Weekly, July 26th, 1999
Panos S. Savvides and colleagues, Department of Clinical Care Research, New England Medical Center, Boston, Massachusetts, evaluated the nephroprotective effective of imipenem/cilastatin (I/C) undergoing bone marrow transplantation (BMT) while receiving continuous infusion cyclosporin A (CsA) to maintain a fixed whole blood level.
Savvides et al. reported their findings in a poster presentation at the 35th annual meeting of the American Society of Clinical Oncology (ASCO) May 15-18, 1999, held in Atlanta, Georgia ("Nephroprotective...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.